Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Infectious Diseases and Therapy|December 18, 2014
In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus AsunaprevirJacques Friborg, Nannan Zhou, Zhou Han, et al.
Biochemical Pharmacology|October 16, 2012
Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activityDennis Hernandez, Paul Falk, Fei Yu, et al.
Analytical and Bioanalytical Chemistry|February 10, 2006
Development of an on-line automated sample clean-up method and liquid chromatography-tandem mass spectrometry analysis: application in an in vitro proteolytic assayDieter Drexler, Deborah J Barlow, Paul Falk, et al.
Antiviral Therapy|August 6, 2011
Development of a chimeric replicon system for phenotypic analysis of NS3 protease sequences from HCV clinical isolatesAmy K Sheaffer, Min S Lee, Dennis Hernandez, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevirFiona McPhee, Jacques Friborg, Steven Levine, et al.
Hepatology (Baltimore, Md.)|March 19, 2013
Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevirFiona McPhee, Dennis Hernandez, Fei Yu, et al.
Viruses|October 26, 2024
Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937Brian McAuliffe, Paul Falk, Jie Chen, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Amy K Sheaffer, Jacques Friborg, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donorBrian L Venables, Ny Sin, Alan Xiangdong Wang, et al.
Bioorganic & Medicinal Chemistry|May 23, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitorsKyle Parcella, Manoj Patel, Yong Tu, et al.
Pageof 2